Hyoscine-n-butyl (Scopex, Unispasmol)
Hyoscine-n-butyl
Adcock ingram limited
Registration
- Applicant
- Adcock ingram limited
- Certificate holder
- Adcock Ingram Limited (Pty) Ltd.
- Registrations
- 4
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Scopex syrup EACH 5,0 ml SYRUP CONTAINS HYOSCINE-N-BUTYL BROMIDE 5,0 mg | 5 mgSyrup | 36032736/11.2/0327Approved 9 June 2021 | Registered | Not determined | PIPIL |
| Unispasmol EACH TABLET CONTAINS HYOSCINE-N-BUTYL BROMIDE A 10 mg | Not listed | C0503 | Cancelled | Not determined | None |
| Scopex tablets EACH TABLET CONTAINS :HYOSCINE-N-BUTYL BROMIDE A 10,0 mg | 10 mgFilm-coated tablet | C0674Approved 8 September 2021 | Old Medicine | Not determined | PIPIL |
| Scopex injection 1 ML HYOSCINE-N-BUTYL BROMIDE A 20 MG | Injection | C0688 | Old Medicine | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
No structure available
This product's active ingredient could not be matched to a single known compound.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.